Benefit-harm trade-offs of intensive blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of six pivotal randomized controlled trials.
Event: ESC Congress 2025
Topic: Clinical
Session: Late-Breaking Clinical Science: new treatments and biomarkers in hypertension
